Accessibility Menu
 
Biodesix logo

Biodesix

(NASDAQ) BDSX

Current Price$14.27
Market Cap$140.09M
Since IPO (2020)-94%
5 Year-96%
1 Year-0%
1 Month+10%

Biodesix Financials at a Glance

Market Cap

$140.09M

Revenue (TTM)

$88.50M

Net Income (TTM)

$35.27M

EPS (TTM)

$-4.73

P/E Ratio

-3.00

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$14.27

Volume

2,814

Open

$15.10

Previous Close

$14.27

Daily Range

$13.59 - $15.10

52-Week Range

$3.44 - $20.21

BDSX News

No articles available.

BDSX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biodesix

Industry

Healthcare Providers and Services

Employees

334

CEO

Scott Hutton

Headquarters

Boulder, CO 80301, US

BDSX Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

-31%

Net Income Margin

-40%

Return on Equity

-383%

Return on Capital

-40%

Return on Assets

-40%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$140.09M

Shares Outstanding

9.86M

Volume

2.81K

Short Interest

0.00%

Avg. Volume

1.45M

Financials (TTM)

Gross Profit

$66.59M

Operating Income

$27.87M

EBITDA

$21.88M

Operating Cash Flow

$23.27M

Capital Expenditure

$259.00K

Free Cash Flow

$23.53M

Cash & ST Invst.

$18.99M

Total Debt

$72.85M

Biodesix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$28.75M

+40.8%

Gross Profit

$23.88M

+48.4%

Gross Margin

83.03%

N/A

Market Cap

$140.09M

N/A

Market Cap/Employee

$513.14K

N/A

Employees

273

N/A

Net Income

$3.98M

+51.8%

EBITDA

$569.00K

+88.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$53.87M

-50.8%

Accounts Receivable

$9.04M

+5.0%

Inventory

$0.00

N/A

Long Term Debt

$71.48M

+16.7%

Short Term Debt

$1.37M

+85.1%

Return on Assets

-40.31%

N/A

Return on Invested Capital

-39.80%

N/A

Free Cash Flow

$629.00K

+112.6%

Operating Cash Flow

$778.00K

+119.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRSNMersana Therapeutics, Inc.
$29.08+0.00%
OKUROnKure Therapeutics, Inc.
$3.99-13.17%
XLOXilio Therapeutics, Inc.
$8.32-4.15%
ALGSAligos Therapeutics, Inc.
$6.66-5.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About BDSX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.